CENTER VALLEY, Pa.,
Feb. 23, 2021 /PRNewswire/
-- Aesculap, Inc. announced today its receipt of FDA 510(k)
clearance for DIR800 3D digital infrared fluorescence for use with
its Aesculap Aeos Robotic Digital Microscope. This clearance
further enhances the fluorescence capabilities of the microscope
which already includes DUV400 3D digital ultraviolet mode.
The DIR800 is an accessory for the Aesculap Aeos Robotic Digital
Microscope and is used in viewing intraoperative blood flow in the
cerebral vascular area including, but not limited to, assessing
cerebral aneurysm and vessel branch occlusion, as well as patency
in neurosurgery. It also aids in the visual assessment of
intraoperative blood flow and vessel patency in bypass
neurosurgical procedures.
With DIR800, the Aesculap Aeos Robotic Digital Microscope
produces excitation light to illuminate the fluorescence properties
of Indocyanine Green (ICG). The generated fluorescence signal
depicts the distribution of the infrared dye in the patient's blood
vessels during surgery.
DIR800 combines infrared fluorescence technology with 3D digital
visualization while also allowing the surgeon and OR team to share
the same high-quality live view and slow motion playback on
multiple 3D 4K monitors. Backlight
illumination aids visualization of nearby non-fluorescing
structures without the need to switch back to white light.
Another key benefit is heads-up positioning to free the surgeon
from the microscope ocular tether, allowing the surgeon, not the
microscope, to dictate ergonomics.
For more information on the Aesculap Aeos Microscope or any of
our neurosurgical solutions, please visit our website at
www.aesculapusa.com, subscribe to our YouTube channel or connect
with us on LinkedIn.
About Aesculap, Inc.
Aesculap, Inc., a B. Braun
company, is part of a 180-year-old global organization focused on
meeting the needs of an ever-changing healthcare community. Through
close collaboration with its customers, Aesculap provides advanced
technologies for neurosurgery, general surgery and sterilization
technologies. Aesculap continues a proud heritage of leadership and
responsiveness as we strive to deliver products and services that
improve the quality of patients' lives. For more information, call
800-282-9000 or visit aesculapusa.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/aesculap-inc-receives-510k-clearance-for-aesculap-aeos-robotic-digital-microscope-dir800-capability-301234014.html
SOURCE Aesculap, Inc.